Welcome to Seeking Alpha's Wall Street Breakfast, where we cover the top news for investors

every morning. We finally made it to Friday, Friday, November 14th. I'm Julie Morgan.

Merck is chasing a new acquisition. The U.S. is working on trade deals with Latin America

and another cybersecurity incident at Dash.

Sedara Therapeutics is up 85% as of the time of this recording.

This follows news that Merck is nearing a deal to buy the company.

The Financial Times reported that Sedera is a drug maker pioneering a long-acting antibody medicine that protects

against flu. A deal valuing Sedera at a premium to its $3.3 billion market cap could be

announced as soon as today. Merck was still vying with another pharmaceutical group for the

biotech late on Thursday before the seller favored its offer.

The exact price of the deal could not immediately be established.

According to the FT, any deal would likely involve cash up front along with additional payouts

tied to future clinical trial milestones.

The United States said on Thursday it will lift tariffs on certain foods and other

imports from Argentina, Ecuador, Guatemala, and El Salvador as part of a new framework agreement

aimed at expanding market access for U.S. companies. Under the agreement, Argentina will offer

preferential access for a variety of U.S. exports,

including medicines, chemicals, machinery, and numerous agricultural products.

Ecuador will lower or eliminate several tariff barriers on key products such as tree nuts,

fresh fruit, and wine.

It will also completely remove a variable tariff on many

agricultural products previously imposed under a different system. The White House says in the

...